Ketamine IV Classic Protocol : Five Years Follow up

Sheba Medical Center11 enrolled

Overview

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Patients who suffer from Major Depressive disorder and are outpatients in our clinic and, received in the years (2014-15) ketamine in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Major Depressive Disorder Drug Abuse Medications Relapse

Interventions

NonOTHER

Follow up

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient who participated in ketamine study 1126 Exclusion Criteria: * None

Locations (1)

The Chaim Sheba Medical Center

Tel Litwinsky, Israel

Outcomes

Primary Outcomes

Mood that will be evaluated using the MADRAS Montgomery-Asberg Depression Rating Scale".

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.